Belaydiagnostics
A Molecular Technologist processes clinical and research samples using advanced technologies for nucleic acid analysis, ensuring compliance with CLIA/CAP regulations and maintaining high standards of quality and integrity.
Headquarters
Chicago, Illinois, United States
Company Size
11-50 employees
Founded
2022
Belay Diagnostics is a specialized diagnostics company focused on CSF liquid biopsy testing for primary and metastatic central nervous system (CNS) malignancies, including brain and spinal cord tumors. The company offers three proprietary tests — Belay Summit™, Belay Ascent™, and Belay Vantage™ — that provide clinicians and patients a minimally invasive, genomically validated alternative to traditional tissue biopsy. Belay Diagnostics operates in the healthcare and oncology diagnostics industry, supporting clinical decision-making around CNS cancer diagnosis, disease monitoring, and treatment selection.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Belaydiagnostics.
Clinical Genomic Technologist II
The Jackson Laboratory
Senior Molecular Technologist - Solid Tumor (1st Shift)
Caris Life Sciences
Senior Molecular Technologist
Exact Sciences Corporation
Clinical Genomic Technologist II
The Jackson Laboratory
Molecular Laboratory Manager
Florida Cancer Specialists & Research Institute
Molecular Research Technician I
Centers for Disease Control and Prevention